Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Chinese herbal medicine composition for the treatment of asymptomatic non-metastatic castration-resistant prostate cancer

A Chinese herbal medicine composition and castration resistance technology, applied in the field of anticancer drugs, can solve the problem of uncontrollable cancer, and achieve the effects of wide and convenient clinical application, simple preparation method, and easy storage and carrying

Inactive Publication Date: 2019-01-04
程惠华
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Furthermore, the cancer is uncontrollable and develops into castration-resistant prostate cancer. In the early stage of the disease, the evil and the good are fighting each other. The good and evil can still compete with the evil. There are no clinical symptoms, and no signs of metastasis are found in imaging examinations.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0010] A Chinese herbal medicine composition for treating asymptomatic non-metastatic castration-resistant prostate cancer, in parts by weight: 30 parts of Banzhilian, 30 parts of Hedyotis diffusa, 27 parts of Radix Astragali, 27 parts of Atractylodes macrocephala, 27 parts of Codonopsis pilosula, 18 parts of Poria cocos, 18 parts of dodder seed, 15 parts of roasted licorice, 9 parts of psoralen, and 9 parts of turmeric. This ratio can be used in asymptomatic non-metastatic castration-resistant prostate cancer patients with an Eastern Cooperative Oncology Group (ECOG) performance status score of 0.

Embodiment 2

[0012] A Chinese herbal medicine composition for treating asymptomatic non-metastatic castration-resistant prostate cancer, in parts by weight: 10 parts of Scutellaria barbata, 10 parts of Hedyotis diffusa, 9 parts of Radix Astragali, 9 parts of Atractylodes macrocephala, 9 parts of Codonopsis pilosula, 6 parts of Poria cocos, 6 parts of dodder seed, 5 parts of roasted licorice, 3 parts of psoralen, and 3 parts of turmeric. This ratio can be used in asymptomatic patients with non-metastatic castration-resistant prostate cancer with an Eastern Cooperative Oncology Group (ECOG) performance status score of 1.

Embodiment 3

[0014] A Chinese herbal medicine composition for treating asymptomatic non-metastatic prostate cancer castration-resistant prostate cancer, in parts by weight: 20 parts of Scutellaria barbata, 20 parts of Hedyotis diffusa, 15 parts of Radix Astragali, 15 parts of Atractylodes macrocephala, and 15 parts of Codonopsis pilosula 12 parts of poria cocos, 12 parts of dodder seed, 10 parts of roasted licorice, 9 parts of psoralen, and 9 parts of turmeric. This ratio is the best ratio and can be used for various asymptomatic non-metastatic castration-resistant prostate cancer patients.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a Chinese herbal medicine composition for curing asymptomatic non-metastatic castration resisting prostatic cancer. The Chinese herbal medicine composition for curing the asymptomatic non-metastatic castration resisting prostatic cancer is prepared from crude medicines of, by weight part, 10-200 parts of sculellaria barbata, 10-200 parts of oldenlandia diffusa, 9-150 parts of astragalus membranaceus, 9-150 parts of white atractylodes rhizome, 9-150 parts of codonopsis pilosula, 6-120 parts of poria cocos, 6-120 parts of semen cuscutae, 5-100 parts of baked licorice, 3-90 parts of fructus psoraleae and 3-90 parts of turmeric. The Chinese herbal medicine composition for curing the asymptomatic non-metastatic castration resisting prostatic cancer is safe and reliable, and free of toxic and side effects, mainly cures the asymptomatic non-metastatic castration resisting prostatic cancer, has functions of preventing androgen in a testis, an adrenal gland and prostatic cancer cells from being synthesized, and reducing PSA (prostate cancer specific antigen) performance, obviously delays clinical deterioration of a metastatic prostatic cancer patient resistant to castration, prolongs time before starting of chemotherapy, and shows a tendency of improving overall survival.

Description

technical field [0001] The invention belongs to the field of anticancer drugs, in particular to a Chinese herbal medicine composition for treating asymptomatic non-metastatic castration-resistant prostate cancer. Background technique [0002] Prostate cancer is common in elderly men. The visceral qi and blood are weakening day by day, exogenous heat and evil toxins, blood stasis block and form cancerous tumors; after modern medical interventions such as surgery, radiotherapy, chemotherapy or endocrine therapy, the cancerous tumors have been initially controlled, but often Deplete the human body. The kidney is the foundation of the innate, and the spleen is the foundation of the acquired. If the spleen is weak, the biochemistry of essence and blood has no source, and there is no way to nourish the viscera, resulting in the disharmony of qi and blood. Insufficient kidney qi can not help yang to transform qi, resulting in imbalance of yin and yang. Furthermore, the cancer was ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K36/9066A61P35/00
Inventor 程惠华骆华春朱榕城
Owner 程惠华
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products